News

Professor Andrew Wilks elected to the Fellowship of the Australian Academy of Science

June 05, 2023

Read more

Aculeus Therapeutics announces IND-enabling studies to advance lead program ACU-0943 towards clinical trials

October 03, 2022

Read more

Aculeus appoints leading preclinical expert as Strategic Safety and Toxicology advisor

July 11, 2022

Read more

Aculeus and Laurus sign CMC development and manufacturing agreement

February 28, 2022

Read more

Aculeus signs agreements to begin IND-enabling studies for STING program

February 13, 2022

Read more

New Appointment - Head of Immunobiology

November 22, 2021

Read more

Aculeus receives TIA Pipeline Accelerator Voucher to support STING program

July 23, 2021

Read more

Aculeus signs service agreement with WEHI to evaluate ACU-757 in models of COVID-19

June 28, 2021

Read more

Aculeus secures CSIRO kick-start program funding

November 09, 2020

Read more

STING and ENPP1 programs in-licenced from CTxT

June 30, 2020

Read more